Funding innovative projects to improve diagnosis and treatment of rare metabolic disorders.
Clinical Research Pilot Project Program
This study is looking for new ways to better understand and treat hyperphenylalaninemia and similar conditions, so patients can benefit from improved tests and treatments in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10701019 on NIH RePORTER |
What this research studies
This research initiative aims to support innovative projects that enhance our understanding and treatment of hyperphenylalaninemia, biopterin defects, and related disorders. It will fund the development of new laboratory tests and instruments, evaluate novel biomarkers, and conduct pilot clinical trials. By leveraging data from longitudinal studies, the project seeks to identify effective strategies for prevention and treatment. Patients may benefit from advancements in diagnostic tools and therapeutic approaches resulting from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with hyperphenylalaninemia, biopterin defects, or related metabolic disorders.
Not a fit: Patients with unrelated metabolic disorders or those not diagnosed with the specific conditions being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic methods and treatment options for patients with rare metabolic disorders.
How similar studies have performed: Previous research has shown promise in developing novel assays and biomarkers for rare diseases, indicating potential success for this approach.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Longo, Nicola — Oregon Health & Science University
- Study coordinator: Longo, Nicola
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.